Impact of 5'-amp-activated Protein Kinase on Male Gonad and Spermatozoa Functions by Thi Mong Diep Nguyen
REVIEW
published: 23 March 2017
doi: 10.3389/fcell.2017.00025






Centre National de la Recherche
Scientifique (CNRS), France
Francisco Iñesta-Vaquera,
University of Dundee, UK
*Correspondence:




This article was submitted to
Signaling,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 23 January 2017
Accepted: 07 March 2017
Published: 23 March 2017
Citation:
Nguyen TMD (2017) Impact of
5’-amp-activated Protein Kinase on
Male Gonad and Spermatozoa
Functions. Front. Cell Dev. Biol. 5:25.
doi: 10.3389/fcell.2017.00025
Impact of 5’-amp-activated Protein
Kinase on Male Gonad and
Spermatozoa Functions
Thi Mong Diep Nguyen 1, 2*
1 Physiologie de la Reproduction et des Comportements, INRA, Nouzilly, France, 2Quy Nhon University, Quy Nhon, Vietnam
As we already know, the male reproductive system requires less energetic investment
than the female one. Nevertheless, energy balance is an important feature for
spermatozoa production in the testis and for spermatozoa properties after ejaculation.
The 5’-AMP-activated protein kinase, AMPK, is a sensor of cell energy, that regulates
many metabolic pathways and that has been recently shown to control spermatozoa
quality and functions. It is indeed involved in the regulation of spermatozoa quality
through its action on the proliferation of testicular somatic cells (Sertoli and Leydig), on
spermatozoa motility and acrosome reaction. It also favors spermatozoa quality through
the management of lipid peroxidation and antioxidant enzymes. I review here the most
recent data available on the roles of AMPK in vertebrate spermatozoa functions.
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INTRODUCTION
One of the fundamental requirements of all cells is to balance ATP consumption and ATP
generation. In this regard, ATP hydrolysis is the major source of cellular energy and the study
of the involvement of specific molecular mechanisms that modulate its availability is required to
understand it better.
In the early 1970s, two groups postulated the existence of a regulator sensitive to the
concentration of cytosolic AMP exhibiting an inhibitory effect on molecules linked to the
synthesis of fatty acids: Acetyl-CoA carboxylase (ACC) (Carlson and Kim, 1973) and 3-hydroxy-
3-methylglutaryl coenzyme A (HMG-CoA) reductase (Beg et al., 1973). In the late 1980s, the
implication of a single inhibitor of both ACC and HMG-CoA reductase, still in response to an
increase in AMP concentration, was demonstrated (Carling et al., 1987). This discovery has made
possible to identify this inhibitory protein as “AMP-activated protein kinase” (Carling and Hardie,
1989). Subsequent research showed that AMPK is concerned with the synthesis of fatty acids, but
also with many other metabolic pathways, such as protein or carbohydrate synthesis, enabling it to
play not only a key role in the intracellular detection of ATP, but also to have a more global role in
maintaining energy balance in cells. From a broader point of view, AMPK was found to act as an
energy regulator at both the cellular and the whole-body levels (Carling, 2004).
Recent investigation has elucidated novel biological actions of AMPK that are highly relevant
to male reproduction. With the advent of new pharmacological approaches to activate AMPK in a
specific manner, the possibility of targeting it in order to improve semen quality is now very close.
The focus of the present review is to examine the evidences concerning the actions of AMPK in
germ cells, providing new insights into the regulation of AMPK and its biological actions in male
reproduction.
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STRUCTURE AND EXPRESSION OF AMPK
AMPK is a heterotrimeric serine/threonine protein kinase
consisting of one catalytic subunit (α) and two regulatory
subunits (β and γ) that exist as multiple isoforms and
splice variants, resulting in the generation of twelve possible
heterotrimeric combinations. The well-conserved genes
encoding these subunits are found in the genomes of essentially
all eukaryotes, including protists, fungi, plants, and animals
(Hardie et al., 2003). AMPK regulates metabolic energy balance
at the whole-body level by responding to hormones and
nutrient signals, which leads to changes in energy homeostasis
(Hardie and Ashford, 2014). Once activated by falling energy
status, it promotes ATP production by increasing the activity
or expression of proteins involved in catabolism (for example,
glucose uptake, glycolysis, fatty acid oxidation andmitochondrial
biogenesis). It does so while conserving ATP by switching off
biosynthetic pathways such as the synthesis of fatty acids,
triglyceride, cholesterol, glucose (via gluconeogenesis) or
glycogen (Hardie, 2011).
The α subunit contains a conventional kinase domain
containing the threonine-172 (Thr172) which is the major site
phosphorylated during activation of AMPK at the N-terminus
and a complex with the β and γ subunits at the C-terminal
regions (Crute et al., 1998). The β subunit contains two conserved
regions: a CBM (carbohydrate-binding module) that is believed
to bind to glycogen particles at the N-terminus (Hudson et al.,
2003; Polekhina et al., 2003), and a bridge between the α
and γ subunits at the C-terminal (Jiang and Carlson, 1997;
Thornton et al., 1998; Cheung et al., 2000). The γ subunit
carries four cystathionine-β-synthase (CBS) domains repeats
which form 2 Bateman domains and is the major binding site
of AMP (Bateman, 1997; Adams et al., 2004; Scott et al., 2004).
AMP, ADP, or ATP can bind the AMPK γ subunit to regulate
AMPK activation through allosteric structural changes in the
catalytic α subunit, modulating phosphorylation by upstream
kinases, including STK11: serine/threonine kinase 11 [LKB1]
(Hawley et al., 2003; Woods et al., 2003), calmodulin-dependent
kinase kinase-β [CaMKKβ] (Woods et al., 2005), or TGF-β-
activated kinase-1 [TAK1] (Momcilovic et al., 2006; Carling
et al., 2008), and regulating the dephosphorylation of Thr172
via phosphatases (phosphatase-2 [PP2A or PP2C]) (Davies et al.,
1995).
In addition to the phosphorylation of Thr172 by AMPK
kinases, AMPK can be activated, more or less directly, by
several pharmacological agents.Metformin and other biguanides,
like phenformin (Dykens et al., 2008), activate AMPK by
inhibiting Complex 1 of the respiratory chain, which, in turn,
decreases intracellular ATP levels (Hardie, 2006; Hawley et al.,
2010). Structurally similar to adenosine, AMPK agonist 5-
aminoimidazole-4-carboxamide-1-b-d-ribofuranoside (AICAR)
is converted by adenosine kinase to the monophosphorylated
nucleotide ZMP. ZMP binds to cystathionine β-synthase (CBS)
domains of AMPK γ subunit, allowing allosteric activation
and increased phosphorylation of Thr172 (Corton et al., 1995).
Moreover, some natural compounds, like resveratrol, which is
found, for instance, in the skin of red grapes (Baur et al.,
2006; Zang et al., 2006), activate AMPK and have a beneficial
effect on metabolic diseases comparable to those of AICAR and
metformin. This compound acts in a quick fashion by inhibiting
the F1F0 mitochondrial ATPase (Hawley et al., 2010) and seems
to activate Sirtuins (SIRT1) through increased NAD+ levels,
induced themselves by AMPK activity (Canto and Auwerx, 2010;
Um et al., 2010). Unlike AICAR and metformin, A-769662, a
new activator of AMPK (Scott et al., 2014), appears to use a
different molecular mechanism to activate AMPK. As it does
not increase cellular ADP/ATP or AMP/ATP ratios, A-769662
is considered to directly activate AMPK in cells, expressing
an AMP-insensitive mutant (Hawley et al., 2010). Moreover,
it does not displace AMP from its binding sites on the γ
subunit, suggesting that it binds at a site different from AMP
even though, like AMP, it causes both allosteric activation and
protection against Thr172 dephosphorylation (Cool et al., 2006;
Goransson et al., 2007; Sanders et al., 2007; Scott et al., 2008).
A-769662 is also selective for activation of β1 rather than β2
complexes, and its effects are abolished by an S108 mutation in
β1 that prevents the autophosphorylation of that serine residue,
suggesting that the binding site involved the β subunit (Sanders
et al., 2007; Scott et al., 2008, 2014). The activity of AMPK is
inhibited by (6-[4-(2-piperidin-1-yl-ethoxy)-phenyl)]3-pyridin-
4-yl-pyrazolo[1,5-a] pyrimidine (Zhou et al., 2001) known as
compound C or dorsomorphin. It can also block the uptake of
AICAR into cells and thus inhibit AICAR stimulatory effects
(Fryer et al., 2002). In addition, when incubated with either
AICAR or metformin, compound C hinders the inactivation of
acetyl CoA carboxylase (ACC) (King et al., 2006).
Among the signaling proteins having a strong impact on the
regulation of the functions of somatic and germ cells, AMPK is a
crucial cellular energy sensor. Relationships between metabolism
and fertility are well established, particularly in the female. Recent
discoveries show that AMPK is also present in male gonad and
spermatozoa in different species [Caenorhabditis elegans (Lee
et al., 2008), oyster (Guevelou et al., 2013), chicken (Nguyen et al.,
2014), boar (Hurtado de Llera et al., 2012, 2013), mouse (Tanwar
et al., 2012; Tartarin et al., 2012), stallion (Cordova et al., 2014),
and human Calle-Guisado et al., 2016; Shabani Nashtaei et al.,
2016]. It is these roles in male gonad and spermatozoa that I will
now describe.
ROLE OF AMPK IN MALE GONAD AND
SPERM PRODUCTION
The male reproductive system in mammals consists of the
testis and a series of ducts and glands. These organs produce
semen, which contains spermatozoa as well as other components.
Spermatozoa differentiate from germ stem cells in the testis and
are transported along the reproductive ducts: the epididymes,
the vas deferens, the ejaculatory duct and the urethra (Caroppo,
2011). Testis not only produce gametes (spermatogenesis), but
also steroid hormones (steroidogenesis) (Rato et al., 2012;
Alves et al., 2013) that control the physiological and behavioral
characteristics of male reproduction. Sertoli cells play pivotal
roles in 1/ the production and differentiation of germ cells
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as well as in 2/ estrogen and specific proteins synthesis (ABP
(androgen-binding protein), SCF (stem cell factor), AMH (anti-
Mullerian hormone), etc.).
AMPK has been detected for the first time in male germinal
cells in 2000, and α1 and γ1 isoforms at a higher level than
α2 or γ3 isoforms in rat testis (Cheung et al., 2000). AMPK
activity in male germinal cells was then presented in 2008 by
Towler et al. The kinase upstream of AMPK, called LKB1s,
plays a crucial role in male fertility in mice (Towler et al.,
2008). Indeed, the absence of LKB1 [LKB1 knockout (KO)] and
AMPKα1 [AMPKα1KO] genes in mice decreases spermatozoa
production, leading to a reduction of mature spermatozoa in
the epididymis in parallel with an increase of the amount
of morphologically abnormal, non-motile spermatozoa (Towler
et al., 2008), as well as a reduction in mitochondrial membrane
potential, a lower basal oxygen consumption, and a decrease
in spermatozoa motility (Tartarin et al., 2012). The AMPK α1
subunit is also localized in mouse Sertoli cells (Bertoldo et al.,
2016) where the AMPK/mTOR signaling pathway is involved
in the regulation of autophagy and apoptosis induced by toxic
substances in Sertoli cells (Duan et al., 2016). AMPK activation
leads to an increase of lactate production, in response to an
increase in glucose uptake and accordingly to increased levels
of GLUT1 (glucose transporter 1) and MCT4 (monocarboxylate
transporter 4) (Galardo et al., 2007; Um et al., 2010). Specific
deletion of the AMPKα1 gene in the Sertoli cells in mice (Sc-
AMPKα1KO mice) has led to a 25% reduction in male fertility,
associated with abnormal spermatozoa with a thin head and
dysregulated energy metabolism with altered lactate, lipid, and
ATP production (Bertoldo et al., 2016). In rat Leydig cells, the
use of the AMPK activator resveratrol decreased testosterone
secretion through a reduction in cholesterol transport into the
mitochondria and decreased conversion of progesterone into
androstenedione (Svechnikov et al., 2009). In chicken testis, the
AMPKα1/2 subunit is found in seminiferous tubules and in
Leydig cells, AMPKβ1/2 and AMPKγ1 subunits in seminiferous
tubules as well, and AMPKγ3 in Leydig cells (Faure et al., 2016).
In chicken (7–10 weeks old), metformin induced a decrease in
testis weight, in the proliferative activity of Sertoli cells and in
germ cells population, but not in spermatogonia population.
Metformin also decreased testosterone levels in chicken Sertoli
cells (Faure et al., 2016). These data suggest that the AMPK
pathway is involved in the nutritional modulation of the male
gonad and spermatozoa production.
Furthermore, the presence of AMPK, especially in its active
form, phospho-AMPK-Thr172, was highlighted in spermatozoa
of boar, stallion, mouse, chicken and human (Hurtado de Llera
et al., 2012, 2013; Tartarin et al., 2012; Cordova et al., 2014;
Nguyen et al., 2014; Calle-Guisado et al., 2016; Shabani Nashtaei
et al., 2016). In boar, the phospho-AMPK form ismainly localized
in the acrosome, the sub-equatorial segment of the head and
in the intermediate part (Hurtado de Llera et al., 2013). In
stallion, phospho-AMPK has been located in the main piece
of the flagellum and the sub-equatorial region of the head
(Cordova et al., 2014). In human, AMPK protein is localized
all along the spermatozoa, in the entire acrosome, the midpiece,
and along the tail of the flagellum (Calle-Guisado et al., 2016;
Shabani Nashtaei et al., 2016). In contrast, phospho-AMPK is
localized only at the most apical part of the acrosome region
and at the spermatozoa tail, and lightly in the post-acrosomal
region of the head and in the midpiece region of the tail (Calle-
Guisado et al., 2016). In chicken, AMPK is mainly localized in
the acrosome, the intermediate part, and the whole flagellum,
but phospho-AMPK is especially present in the flagellum and the
acrosome, and with a much lower intensity in the intermediate
part (Nguyen et al., 2014). The localization of phospho-AMPK
in spermatozoa flagellum of several species suggests that it
acts through the phosphorylation of protein substrates involved
in the functioning of the axoneme central apparatus that is
essential for flagellar motility. The mechanism could be similar to
that demonstrated for a testicular AMPK-related kinase: TSSK2
(Testis-Specific Serine Kinase 2), a Ser/Thr protein kinase close
to AMPK (Scott et al., 2008). In vitro, TSKK2 phosphorylates
SPAG16L, a protein of the axoneme central apparatus which
is essential for mouse spermatozoa flagellar motility (Moreno
et al., 2008). By contrast, in chicken, phospho-AMPK-Thr-172
is mainly present in the flagellum and the acrosome, and much
less in the intermediate part (Nguyen et al., 2014). These results
are in agreement with the fact that the ATP production is not
limited to the spermatozoa intermediate piece (mitochondrial
respiration) but may also occur at other places via anaerobic
glycolysis (Zhou et al., 2001; Scott et al., 2014). Therefore, the
AMPK distribution profile in spermatozoa cells suggests that,
depending on the species, it promotes in different ways both
motility and acrosome reaction. The links between differences
in subcellular localization of AMPK and spermatozoa biological
characteristics of different species, however, have not yet been
defined. In invertebrates, AMPK has also been highlighted in
2013 in oyster’s male and female germ cells, where it is involved
in the glucose and fatty acids metabolism (Guevelou et al., 2013).
ROLE OF AMPK IN SPERMATOZOA
FUNCTIONS
The key role of AMPK in the control of cell energy homeostasis
has placed it in a position of an important kinase regarding
the regulation of those spermatozoa functions. Indeed, these
functions, such as motility, acrosome reaction, and fertilization,
are very dependent on energy levels (Hurtado de Llera et al., 2012,
2013; Tartarin et al., 2012; Cordova et al., 2014; Nguyen et al.,
2014, 2015; Calle-Guisado et al., 2016; Shabani Nashtaei et al.,
2016). AMPK activation in spermatozoa by pharmacological
factors favors motility (Nguyen et al., 2014, 2015; Hurtado de
Llera et al., 2015; Shabani Nashtaei et al., 2016), acrosome
reaction and spermatozoa ability to successfully fertilize the
oocyte (Nguyen et al., 2014, 2015). AMPK is also implicated
in the mitochondrial membrane potential, spermatozoa plasma
membrane fluidity and organization, and acrosome integrity
(Hurtado de Llera et al., 2013; Shabani Nashtaei et al., 2016).
By contrast, pharmacological inhibition of AMPK, for example
with compound C, leads to a reduction in motility parameters
such as the percentages of motile and rapid spermatozoa or
their curvilinear velocity and average path velocity, in boar,
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chicken, and human spermatozoa (Hurtado de Llera et al., 2012;
Nguyen et al., 2014, 2015; Calle-Guisado et al., 2016; Shabani
Nashtaei et al., 2016). Unexpectedly, compound C does not affect
spermatozoa functions in stallion (Cordova et al., 2014).
Different AMPK activators exhibit various effects on
spermatozoa functions. Metformin promotes no deleterious
effect in mouse spermatozoa quality, viability, or integrity
of the acrosome membrane, except for a slight reduction in
spermatozoa motility when used at high concentration (5mM),
due to a reduction of active mitochondria (Bertoldo et al., 2014).
When mouse semen is cryopreserved, spermatozoa viability
and membrane integrity is increased by pre-incubating it with
metformin before freezing. This also significantly increases the
percentage of fertilized oocytes (Bertoldo et al., 2014). Using
fresh or frozen-thawed chicken spermatozoa demonstrated
that exposure to metformin significantly improves AMPK
phosphorylation, spermatozoa motility, viability, and percentage
of spermatozoa able to undergo a successful acrosome reaction
(Nguyen et al., 2015). The use of metformin in cryopreservation
protocols actually seems to have an overall beneficial effect
on the quality of cryopreserved semen, improving its quality
and fertilization ability, in response to the activation of the
AMPK pathway. The other AMPK activators, AICAR and
A-769662, exhibit the same beneficial effects as metformin.
AICAR increases chicken spermatozoa quality (motility,
viability and acrosome reaction) (Nguyen et al., 2014, 2015),
and A-769662 improves boar spermatozoa motility (Hurtado
de Llera et al., 2015). Supporting a relevant role of AMPK in
spermatozoa functions, Tartarin et al. have shown a significant
reduction in the fertilizing capacity in mouse epididymal
spermatozoa lacking the AMPK catalytic subunit α1 gene
[AMPKα1 KO]. This is due to asthenozoospermia and higher
rate of morphological and functional abnormalities linked to
mitochondrial dysgenesis. There is, however, no changes in testis
morphology or spermatozoa production rate. Furthermore,
the increase in intra-testicular cholesterol and testosterone,
in parallel with a decrease in LH and FSH levels in KO mice,
show that the lack of AMPK activation seems to result in an
increase of androgens levels, which can negatively influence
spermatozoa quality, and consequently, male fertility (Tartarin
et al., 2012). Regarding human germ cells, it has been recently
shown that resveratrol could activate and phosphorylate AMPK
in frozen–thawed spermatozoa, and thus help in restoring their
functions, and that compound C had opposite effects (Shabani
Nashtaei et al., 2016).
ROLE OF AMPK IN LIPID PEROXIDATION
AND ANTIOXIDANT ENZYMES
Oxygen-free radicals, also known as reactive oxygen species
(ROS), can be either harmful or beneficial. They are needed for
the maturation of cellular structures and help the defense system,
supporting cell proliferation and survival pathways (Sundaresan
et al., 1995; Echtay et al., 2002; Pacher et al., 2007). But if they are
produced in excess, they can damage the cells components and
hamper physiological functions (Droge, 2002; Fulda et al., 2010;
Kong and Lin, 2010; Martin, 2010; Navarro and Boveris, 2010).
In male reproduction, it has been observed that ROS can
disrupt the spermatozoa response to calcium signaling and
inhibit the ionophore-induced sperm-oocyte fusion (Aitken and
Clarkson, 1987). This could be the result of decreased plasma
membrane fluidity and of membrane-bound enzymes and/or
ion channels malfunctions, as a consequence of peroxidation
(Aitken et al., 1989). ROS have a negative effect on motility
which might be due to the depletion of ATP by H2O2 inhibiting
oxidative phosphorylation and/or glycolysis, and thus hindering
ATP restoration (deLamirande and Gagnon, 1992a). This process
could happen by decreasing phosphorylation of axonemal
proteins involved in spermatozoa motility (de Lamirande and
deLamirande and Gagnon, 1992b), by depressing glycolytic
flux (Baumber et al., 2000), or through products of lipid
peroxidation like malondialdehyde or 4-hydroxynonenol (4HN),
inhibiting anaerobic glycolysis, DNA, RNA, and protein synthesis
(Comporti, 1989).
AMPK appears to be involved in the mechanisms protecting
the cells against toxic effects of ROS. Although there are
still unknown factors or difficulties in assessing significance of
ROS, the goal of many researches is to prevent or counteract
their deleterious effects. In forms of diabetes in which the
activity of AMPK is strongly impaired, reactivation of AMPK
could counteract the negative effects of oxidative stress linked
to this metabolic disease (Ceolotto et al., 2007). Resveratrol,
by activating AMPK, reduces superoxide anion and protein
carbonyl in type II diabetic mice (Chang et al., 2011), and
metformin reduces NAFLD in obese Ob/Ob mice submitted to
fat diet (Viollet et al., 2012). It is also possible that the AMPK
activation caused by resveratrol helps the mitochondria in its
defense against oxidative stress by inhibiting ROS generation
and permeability transition; it could do that while playing a part
in the downstream inhibitory phosphorylation of GSK3b at the
same time (Shin et al., 2009). The positive effect of metformin
on steatosis depends on the activation of AMPK secondary
to the inhibition of complex I of the respiratory chain and
the generated energy deficiency (augmented AMP/ATP ratio).
An “antioxidant” effect of AMPK has been shown in different
systems, and in particular in tumor cells deficient in LKB1 of
lung adenocarcinoma. In this model, AMPK may increase the
levels of intracellular NADPH in different ways: by the activation
of the oxidation of fatty acids and by the inhibition of fatty
acid synthesis to neutralize the cytotoxic ROS (Jeon et al., 2012).
The antioxidant defense and glutathione regeneration efficiency
is greatly improved by NADPH since it is a very important
source of reducing equivalent (Fico et al., 2004). Antioxidant
enzymes depending on NADPH, like those of the thioredoxin
and glutaredoxin classes, are heavily involved in the maintenance
of redox homeostasis due to the regulation of thiol-disulfide
exchange (Kalinina et al., 2008; Myers and Myers, 2009). While
under oxidative stress conditions, AMPK is activated and helps
to increase NADPH production through pentose phosphate
pathway by starting the glytolytic flux (Wu and Wei, 2012).
In the male reproductive function, a link between AMPK
and antioxidant mechanisms also exists. Thus, in the testis of
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diabetic and obese rats, the use of metformin induces a reduction
in the levels of lipid peroxidation (LPO) accompanied by a
stimulation of steroidogenesis, a restoration of spermatogenesis,
and an increase in spermatozoa concentration and motility
(Fang et al., 2012; Nasrolahi et al., 2013). In recent years,
the involvement of AMPK in the regulation of ROS or
LPO concentrations and the activity of the main antioxidant
enzymes in spermatozoa has been demonstrated (Nguyen et al.,
2015). The addition of an AMPK activator, metformin or
AICAR, before cryopreservation increases the phosphorylation
of AMPK while reducing the production of ROS and LPO in
chicken frozen/thawed spermatozoa. At the same time, AICAR
and metformin increase the activity of antioxidant enzymes
superoxide dismutase (SOD), glutathione peroxidase (GPx) and
glutathione reductase (GR) in the cryopreserved semen. It
has been observed that human spermatozoa incubated with
AMPK activator resveratrol have decreased ROS levels (O.−2
and H2O2), while AMPK inhibitor increased them (Shabani
Nashtaei et al., 2016). Resveratrol had the same effects on
mouse spermatozoa, where a 15 µg/mL dosage significantly
decreased ROS (Mojica-Villegas et al., 2014). This shows that
AMPK activity is limiting ROS production in endothelial cells
(Kim et al., 2008), in mice endothelial progenitor cells (by
restoring manganese superoxide dismutase (MnSOD) levels)
(Wang et al., 2011), and in cryopreserved chicken spermatozoa
(Nguyen et al., 2015). However, the mechanisms by which AMPK
activators would act on ROS and antioxidant enzyme systems in
spermatozoa are still unclear.
AMPK is known to be involved in the renewal of cellular
mitochondrial content by stimulating the degradation of
defective mitochondria through ULK1/2 (Unc51-like kinase) on
the one hand, and by activating biogenesis new mitochondria
via PGC1α on the other hand, and thus, indirectly, on
antioxidant systems (Canto et al., 2009; Aquilano et al., 2010).
But since AMPK stimulation of the regeneration of NADPH
(Williams and Ford, 2004) by the pentose phosphate pathway
has been demonstrated in mammalian spermatozoa, it probably
contributes to the antioxidant system through stimulation
of GPx, and could also, as a result, have a role in this
function. AMPK could have a part in the up-regulation of
several antioxidant enzymes (Colombo and Moncada, 2009;
Calegari et al., 2011). It can directly phosphorylate the
FIGURE 1 | Diagram of the regulation of AMPK activity in male reproduction. The diagram represents a summary of AMPK actions in the male reproductive
system (testis, Sertoli cells, spermatozoa). T, testosterone; LH, luteinizing hormone; FSH, follicle-stimulating hormone; ABP, androgen-binding protein; SCF, Stem Cell
Factor; AMH, anti-Mullerian hormone. GLUT, glucose transporter; MCT, monocarboxylate transporter; ROS, reactive oxygen species; LPO, lipid peroxidation.
↑, increase; ↓, decrease.
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forkhead transcription factor (FOXO) to promote its nuclear
translocation and the formation of subsequent transcription
activation complex (Greer et al., 2007). Activating AMPK–FOXO
pathway helps up-regulating the expression of thioredoxin and
peroxiredoxin and thus reduces oxidant-induced ROS (Chiribau
et al., 2008; Li et al., 2009). Through usage of endothelial cells with
silenced AMPK α1 subunit, it has also been shown that AMPK
induced the expression of genes playing a role in antioxidant
defense (like MnSOD, catalase, γ-glutamylcysteine synthase, or
thioredoxin) (Colombo and Moncada, 2009). This procedure
goes along with a decreased mitochondrial content and increased
ROS, suggesting that AMPKα1 involvement in endothelial cells
happens in bothmitochondrial content and antioxidant defenses.
This method also significantly reduced FOXO3a at the protein
andmRNA levels, providing further evidence of its role in AMPK
antioxidant defense regulation.
I believe that these data will be useful to develop and improve
the methodologies of semen handling and storage. Moreover,
the positive effects of AMPK stimulation on the functions
of spermatozoa remain after cryopreservation (chicken, mice),
which supports the hypothesis of its “protector” role on gametes
after exposure to extreme heat and osmotic stress conditions
encountered during the freeze/thaw process (Bertoldo et al., 2014;
Nguyen et al., 2015).
SPERMATOZOA AMPK: A LINK BETWEEN
ENERGY METABOLISM AND FERTILITY
The spermatozoa energy in the form of ATP is mainly
obtained from aerobic metabolic (involving the citric acid
cycle and oxidative phosphorylation) and/or anaerobic pathways
through glycolysis. The metabolic pathways of spermatozoa
are mainly localized in mitochondria (Krebs cycle, oxidative
phosphorylation) which are found themselves in the intermediate
part, the cytoplasm, the fibrous sheath of the flagellum, and
the acrosome (Ferramosca and Zara, 2014). AMPK helps to
regulate the mitochondrial membrane potential in spermatozoa
of boars (Hurtado de Llera et al., 2013) and mice (Tartarin et al.,
2012; Bertoldo et al., 2014). An increase in the production of
ATP and lactate in spermatozoa cells was observed after the
stimulation of AMPK by pharmacological activators (metformin
or AICAR) in chicken (Nguyen et al., 2014, 2015). AICAR
also stimulates the production of citrate, an intermediate in the
Krebs cycle. In the particular case of cryopreservation, after
thawing, many spermatozoa die or are unable to move due to
alterations of the flagellum or the intermediate piece, or unable
to accomplish the acrosome reaction. All these alterations result
in a decreased fertility. In these conditions, spermatozoa require
a very large amount of energy to restore their fertilizing capacity.
The addition of metformin or AICAR before cryopreservation
would restore a portion of the energy needed by stimulating the
anaerobic metabolism and, for AICAR, the aerobic metabolism
(Nguyen et al., 2015). AMPK is therefore essential to keep
spermatozoa at the energy level necessary for the conduct of
fertilization, especially in “stressful” conditions.
CONCLUSIONS
All the previously published data and my own results suggest an
important role of AMPK in the development of the male gonad
and spermatozoa production (Figure 1). It is also involved in
spermatozoa functions: in motility and acrosome reaction as well
as in the energy and redox capacities in order to regulate cellular
processes necessary for successful fertilization. Its role in the
regulation of antioxidant defenses of the cell particularly affects
the in vitro retention capacity, which is especially solicited during
the freezing of semen. From a broader point of view, AMPK
could become a therapeutic target for limiting infertility and
improving biotechnologies of artificial insemination and semen
conservation. Further work is needed to study the involvement
of AMPK in human male reproductive function.
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